GERON CORP Amortization of Debt Discount (Premium)
GERON CORP (GERN) reported Amortization of Debt Discount (Premium) of $51.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2014-03-17
- GERON CORP amortization of debt discount (premium) for the quarter ending 2011-12-31 was $18.00K.
- GERON CORP amortization of debt discount (premium) for the quarter ending 2010-12-31 was $0.00.
- GERON CORP amortization of debt discount (premium) for fiscal 2011 was $51.00K.
- GERON CORP amortization of debt discount (premium) for fiscal 2010 was $0.00.
- GERON CORP amortization of debt discount (premium) for fiscal 2009 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|
| 2011-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $51.00K 10-K · filed 2014-03-17 | |
| 2011-09-30 | $33.00K 10-Q · filed 2012-11-02 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-07 | $0.00 10-K · filed 2012-03-07 | |
| 2010-09-30 | $0.00 10-Q · filed 2011-11-03 | ||
| 2009-12-31 | $0.00 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |